OSCR · Oscar Health, Inc. · Metrics
$27.57
-2.27 (-7.61%)
At close · Nov 18
View the 10-K filed Feb 13, 2026
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Customer concentration
— top customer 93% of revenue
One customer — 93% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, 93% of premiums were earned directly from CMS and 7% were from our members.”
Market Cap
$8.57B
Shares
310.69M
Volume · Nov 18
7.4M
Avg daily vol (3M)
5.28M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
OSCR metrics
86 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$27.57
Market cap
$8.57B
Price action
23 metricsPrice change (1W)
-14.1%
Price change (30D)
-15.3%
Price change (3M)
-14.6%
Price change (6M)
+17.7%
Price change (YTD)
+91.9%
Price change (1Y)
+87.4%
Trailing year
Price change (5Y)
+159.1%
52-week high
$35.19
52-week low
$10.85
Change from 52-week high
-21.7%
Change from 52-week low
+154.1%
Annualized volatility
66.1%
Annualized volatility (3M)
52.5%
Implied volatility (30D)
60.4%
IV rank (1Y)
39.4
IV percentile (1Y)
7.0
Beta
1.5
RSI (14D)
36.3
Price vs SMA 50
-13.4%
Price vs SMA 200
+11.8%
Avg volume (3M)
5.28M
Relative volume
1.4
Average dollar volume
$167.86M
Company
3 metricsSector
Healthcare
Industry
Healthcare Plans
Shares outstanding
310.69M
Valuation
12 metricsP / E (TTM)
11.2
Trailing earnings · reciprocal yield 9.0%
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 1,157.5%
EV / EBITDA
1.6×
reciprocal yield 63.9%
EV / EBIT
1.6×
reciprocal yield 62.1%
P / sales
0.5×
reciprocal yield 204.0%
P / book
3.9
reciprocal yield 25.9%
FCF yield
48.4%
TTM · current market cap
Buyback yield
—
P / FCF
2.1
reciprocal yield 48.4%
P / operating cash flow
2.0
reciprocal yield 48.8%
Earnings yield
10.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-05
Profitability
9 metricsGross margin
—
Operating margin
5.4%
Trailing 12 months
Net margin
4.9%
Gross profit (TTM)
—
Operating profit (TTM)
$936.99M
Net income (TTM)
$855.47M
Trailing 12 months
Diluted EPS (TTM)
$2.47
FCF margin
23.7%
Effective tax rate
5.4%
Growth
11 metricsRevenue growth YoY
+72.1%
Year over year
Net income growth YoY
-1,842.5%
Revenue (TTM)
$17.47B
Trailing 12 months
EPS growth YoY
-1,790.0%
Shares change YoY
+33.6%
Year over year · more shares
Revenue CAGR (3Y)
+43.5%
Revenue CAGR (5Y)
+90.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+44.4%
FCF CAGR (5Y)
+38.4%
Quality
14 metricsReturn on equity
38.5%
Return on assets
8.5%
Debt / equity
0.2
Current ratio
1.1
EBITDA (TTM)
$964.46M
Free cash flow (TTM)
$4.14B
Quick ratio
1.1
Interest coverage
68.3
Net debt / EBITDA
-4.2
Return on invested capital
—
Trailing 12 months
Net cash
$4.03B
Latest balance sheet
Cash & equivalents
$4.47B
Total assets
$10.01B
Total debt
$432.41M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$4.18B
Capital expenditures (TTM)
$40.93M
R&D (TTM)
—
SG&A (TTM)
$2.63B
Stock compensation (TTM)
$77.00M
R&D / revenue
—
Stock compensation / revenue
0.4%
Ownership (13F)
9 metrics13F filers
422
13F filer change QoQ
+13
Institutional ownership
67.2%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.6%
Holder tenure
12.2
Price vs estimated holder cost
+63.3%
Ownership (registered funds)
1 metricsIndex-fund ownership
12.9%
Short interest
3 metricsShort interest
5.4%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
−$26.17M
Insider-sentiment score
18 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1568651
CUSIP
687793109
13F (30d)
434 filings
403 filers
Visit website
Investor relations